NVO Novo Nordisk A/S
Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals > Pharmaceuticals | NYSE, LargeCap, ObesityDrugs | Last Price: 37.45 | 2026-02-27 | Atrp: 5.68
Sat 21 Feb 2026 to Fri 27 Feb 2026: Score 17
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 1.48 | 1.04 | ▼ -29.73% | Bullish. Lower is better. Significant improvement |
| â | Price Sales TTM | 0.6823 | 0.541 | ▼ -20.71% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 7.1475 | 5.4683 | ▼ -23.49% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 4.8053 | 3.768 | ▼ -21.59% | Bullish. Lower is better. Significant improvement Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 9.4759 | 7.4303 | ▼ -21.59% | Bullish. Lower is better. Significant improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Short Percent | 0.94% | 0.84% | ▼ -10.64% | Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | EPS Estimate Next Year | 21.5833 | 21.8139 | ▲ 1.07% | Bullish. Higher is better. Slight raised expectations for further out Expected earnings per share next year |
| â | Enterprise Value | $235.92B | $184.15B | ▼ -21.94% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sat 14 Feb 2026 to Sat 21 Feb 2026: Score 3
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Price Sales TTM | 0.7132 | 0.6823 | ▼ -4.33% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Institutional Ownership | 9.076% | 9.49% | ▲ 4.56% | Bullish. Higher is better. Slight increase; continued strong interest from big investors Percentage held by institutions like mutual funds |
| â | EPS Estimate Next Year | 22.0496 | 21.5833 | ▼ -2.11% | Bearish. Higher is better. Slight lowered expectations for further out Expected earnings per share next year |
Sat 07 Feb 2026 to Sat 14 Feb 2026: Score -8
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Percent | 0.84% | 0.94% | ▲ 11.9% | Bearish. Lower is better. Moderate increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Enterprise Value/Revenue | 4.5851 | 4.8053 | ▲ 4.8% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 9.0416 | 9.4759 | ▲ 4.8% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | PEG Ratio | 3.9856 | 4.1258 | ▲ 3.52% | Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | EPS Estimate Next Year | 22.3095 | 22.0496 | ▼ -1.16% | Bearish. Higher is better. Slight lowered expectations for further out Expected earnings per share next year |
| â | Forward PE | 12.7551 | 13.21 | ▲ 3.57% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Book MRQ | 6.9044 | 7.1475 | ▲ 3.52% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Short Ratio | 1.45 | 1.48 | ▲ 2.07% | Bearish. Lower is better. Slight decline |
| â | Price Sales TTM | 0.7911 | 0.7132 | ▼ -9.85% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value | $223.48B | $235.92B | ▲ 5.56% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Fri 30 Jan 2026 to Sat 07 Feb 2026: Score -6
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Quarterly Revenue Growth YOY | 51% | -81% | ▼ -249.02% | Bearish. Higher is better. Quarterly revenue growth YOY turned from growth to decline; signs of deterioration. Year-over-year growth in quarterly revenue |
| â | PEG Ratio | 2.8381 | 3.9856 | ▲ 40.43% | Bearish. Lower is better. Significant increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Return On Equity TTM | 71.47% | 60.7% | ▼ -15.07% | Bearish. Higher is better. Return on equity TTM growth slowing. Efficiency in generating profits from shareholders' equity |
| â | Return On Assets TTM | 21.11% | 17.43% | ▼ -17.43% | Bearish. Higher is better. Return on assets TTM growth slowing. Efficiency in generating profits from total assets |
| â | Enterprise Value | $275B | $223.48B | ▼ -18.73% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | EBITDA | $165493M | $153295M | ▼ -7.37% | Bearish. Higher is better. Decline in earnings before interest, taxes, depreciation, and amortization; indicates weaker operational cash flow Earnings before interest, taxes, depreciation, and amortization |
| â | Wall Street Target Price | 59.166 | 54.8183 | ▼ -7.35% | Bearish. Higher is better. Lower analyst expectations, pointing to decreased optimism for future performance Analysts' consensus target price for the stock |
| â | EPS Estimate Current Year | 23.166 | 21.1233 | ▼ -8.82% | Bearish. Higher is better. Slight decrease; reduced outlook for current year earnings Expected earnings per share this year |
| â | Earnings Per Share | 3.76 | 3.63 | ▼ -3.46% | Bearish. Higher is better. Slight decline in earnings per share Profit allocated to each outstanding share |
| â | Gross Profit TTM | $263334M | $254687M | ▼ -3.28% | Bearish. Higher is better. Slight decline, but margins may be holding Revenue minus cost of goods sold over the trailing twelve months |
| â | Revenue TTM | $315602.99M | $309064.01M | ▼ -2.07% | Bearish. Higher is better. Slight top-line contraction Total revenue over the trailing twelve months |
| â | Revenue Per Share TTM | 71.001 | 69.562 | ▼ -2.03% | Bearish. Higher is better. Slight decline Revenue generated per outstanding share over the trailing twelve months |
| â | Price Sales TTM | 0.8265 | 0.7911 | ▼ -4.28% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Book Value | 6.1328 | 6.8861 | ▲ 12.28% | Bullish. Higher is better. Moderate increase; stock now trades closer to book value Net asset value of the company per share |
| â | Forward PE | 16.1812 | 12.7551 | ▼ -21.17% | Bullish. Lower is better. Significant improvement Stock price divided by expected future earnings |
| â | Enterprise Value/Revenue | 5.4324 | 4.5851 | ▼ -15.6% | Bullish. Lower is better. Moderate improvement Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 11.3567 | 9.0416 | ▼ -20.39% | Bullish. Lower is better. Significant improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Price Book MRQ | 9.6436 | 6.9044 | ▼ -28.4% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
| â | Quarterly Earnings Growth YOY | -271% | -51% | ▲ 82.26% | Bullish. Higher is better. Quarterly earnings growth YOY decline slowing; potential stabilization. Year-over-year growth in quarterly earnings |
Fri 23 Jan 2026 to Fri 30 Jan 2026: Score 19
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 2.04 | 1.45 | ▼ -28.92% | Bullish. Lower is better. Significant improvement |
| â | Short Percent | 0.96% | 0.84% | ▼ -12.5% | Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Forward PE | 17.3611 | 16.1812 | ▼ -6.8% | Bullish. Lower is better. Slight improvement Stock price divided by expected future earnings |
| â | Price Sales TTM | 0.8762 | 0.8265 | ▼ -5.67% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 10.4175 | 9.6436 | ▼ -7.43% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 5.8027 | 5.4324 | ▼ -6.38% | Bullish. Lower is better. Slight improvement Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 12.1308 | 11.3567 | ▼ -6.38% | Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Wall Street Target Price | 57.6015 | 59.166 | ▲ 2.72% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | Book Value | 5.9736 | 6.1328 | ▲ 2.67% | Bullish. Higher is better. Slight increase; stock now trades closer to book value Net asset value of the company per share |
| â | Earnings Per Share | 3.65 | 3.76 | ▲ 3.01% | Bullish. Higher is better. Slight increase in earnings per share Profit allocated to each outstanding share |
| â | Enterprise Value | $271.54B | $275B | ▲ 1.28% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | PEG Ratio | 2.6568 | 2.8381 | ▲ 6.82% | Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
Wed 14 Jan 2026 to Fri 23 Jan 2026: Score -9
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | PEG Ratio | 2.5514 | 2.6568 | ▲ 4.13% | Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 16.6667 | 17.3611 | ▲ 4.17% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 0.8397 | 0.8762 | ▲ 4.35% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 9.9916 | 10.4175 | ▲ 4.26% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value | $276.61B | $271.54B | ▼ -1.83% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Enterprise Value/Revenue | 5.6141 | 5.8027 | ▲ 3.36% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 11.7364 | 12.1308 | ▲ 3.36% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Wall Street Target Price | 54.8335 | 57.6015 | ▲ 5.05% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
Tue 06 Jan 2026 to Wed 14 Jan 2026: Score -19
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 1.54 | 2.04 | ▲ 32.47% | Bearish. Lower is better. Significant decline |
| â | PEG Ratio | 2.2234 | 2.5514 | ▲ 14.75% | Bearish. Lower is better. Moderate increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 14.5138 | 16.6667 | ▲ 14.83% | Bearish. Lower is better. Moderate decline Stock price divided by expected future earnings |
| â | Price Book MRQ | 8.7131 | 9.9916 | ▲ 14.67% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 4.8672 | 5.6141 | ▲ 15.35% | Bearish. Lower is better. Moderate decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 10.1749 | 11.7364 | ▲ 15.35% | Bearish. Lower is better. Moderate decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Short Percent | 0.85% | 0.96% | ▲ 12.94% | Bearish. Lower is better. Moderate increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Price Sales TTM | 0.7759 | 0.8397 | ▲ 8.22% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Wall Street Target Price | 53.2499 | 54.8335 | ▲ 2.97% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | EPS Estimate Next Year | 21.6891 | 22.3826 | ▲ 3.2% | Bullish. Higher is better. Slight raised expectations for further out Expected earnings per share next year |
| â | Enterprise Value | $241.65B | $276.61B | ▲ 14.47% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sun 21 Dec 2025 to Tue 06 Jan 2026: Score -15
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | PEG Ratio | 2.0147 | 2.2234 | ▲ 10.36% | Bearish. Lower is better. Moderate increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 13.1579 | 14.5138 | ▲ 10.3% | Bearish. Lower is better. Moderate decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 0.6771 | 0.7759 | ▲ 14.59% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Short Ratio | 1.31 | 1.54 | ▲ 17.56% | Bearish. Lower is better. Moderate decline |
| â | Price Book MRQ | 8.0156 | 8.7131 | ▲ 8.7% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 4.5821 | 4.8672 | ▲ 6.22% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 9.5789 | 10.1749 | ▲ 6.22% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Short Percent | 0.88% | 0.85% | ▼ -3.41% | Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Enterprise Value | $226.91B | $241.65B | ▲ 6.49% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |